Electronic Patient Decision Support System for Patients With Type 2 Diabetes (DiaPaDeSS) (DiaPaDeSS)
Mobile Health, Type 2 Diabetes, Patient Activation
About this trial
This is an interventional supportive care trial for Mobile Health focused on measuring Mobile Health, Type 2 Diabetes, Patient Activation, Decision Support System, Self-Management, Nursing, Randomized Controlled Trial
Eligibility Criteria
Inclusion Criteria: Patients with type 2 diabetes who had been followed up and treated at the Endocrinology and Metabolic Diseases Polyclinic Aged between 18-65 years Patients who know their diagnosis and can verbally express it Have been diagnosed with type 2 diabetes for at least six months Who are literate Who have internet access at home, who have one of the tools such as a computer, tablet or smartphone and can use these tools Consented to participate in the study Had no other psychiatric or mental barriers to answering the questions, language or cognitive difficulties, and barriers to verbal or written communication Exclusion Criteria: Diagnosed with myocardial infarction, stroke or diabetic foot in the last six months Diagnosed with type 1 diabetes or gestational diabetes Diagnosed with terminal illness Using steroid therapy Had pregnant Having dementia and cognitive deficits Having retinopathy or advanced neuropathy Patients whose information is not allowed to be accessed
Sites / Locations
- Akdeniz University
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
DiaPaDeSS intervention group
Control Group
DiaPaDeSS will be introduced to participants with type 2 diabetes during face-to-face interviews. The DiaPaDeSS intervention group will have access to all the contents of the DiaPaDeSS, which includes the patient education information about type 2 diabetes, self-management practice tasks (daily, weekly, quarterly), type 2 diabetes patient education program according to DiaPaDeSS algorithms, and measurement questionnaires. During the follow-up period, the participants in the DiaPaDeSS intervention group will take DiaPaDeSS messages once a week and be reminded to use the education program. The DiaPaDeSS will be asked to use it for three months on daily and weekly inputs. During the follow-up period, the participants can contact the researcher via 24/7 on the DiaPaDeSS. Participants in the DiaPaDeSS intervention group will also receive routine patient education and hospital follow-ups.
DiaPaDeSS will be introduced to participants with type 2 diabetes in the control group during face-to-face interviews. The control group will have access to only these fields self-management practice tasks (daily, weekly, quarterly), and measurements questionnaires. The diabetes patient education brochure of the Ministry of Health will be sent to the phones of the active control group in pdf format. Participants in the DiaPaDeSS group will also receive routine patient education and routine hospital follow-up during the three-month follow-up period..